Nucleolar organizer regions and PCNA expression in prostatic cancers

Area of Science:

• Uropathology
• Oncology
• Cell Biology

Background:

• Prostate cancer diagnosis and prognosis can be improved by identifying reliable biomarkers.
• Argyrophilic nucleolar organizer regions (AgNOR) and proliferating cell nuclear antigen (PCNA) are markers of cell proliferation.
• Evaluating the diagnostic and prognostic utility of AgNOR and PCNA in prostate cancer is crucial.

Purpose of the Study:

• To investigate the diagnostic and prognostic value of AgNOR counts and PCNA expression in prostate adenocarcinomas.
• To compare the efficacy of AgNOR and PCNA as biomarkers for prostate cancer.
• To explore the relationship between AgNOR morphology and clinicopathological features.

Main Methods:

• Analysis of AgNOR counts and morphological types (A, B, C, D) in 79 prostate adenocarcinomas.
• Immunohistochemical staining for PCNA in 54 prostate adenocarcinomas.
• Correlation of AgNOR counts and PCNA positivity with clinicopathological parameters and patient survival.

Main Results:

• AgNOR counts were significantly higher in prostate cancer than benign lesions (4.2 vs. 1.9).
• AgNOR counts correlated with histological differentiation, nuclear anaplasia, and invasion.
• Higher AgNOR counts (≥4.3) were associated with significantly poorer patient survival.
• PCNA positivity correlated with mitosis but not survival; AgNOR was more valuable prognostically and diagnostically than PCNA.

Conclusions:

• AgNOR counts, particularly with morphological classification, are valuable diagnostic and prognostic markers for prostate cancer.
• AgNOR provides superior diagnostic and prognostic information compared to PCNA in prostate lesions.
• Further research into AgNOR morphology could refine its clinical utility in prostate cancer management.